SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-19-074839
Filing Date
2019-03-14
Accepted
2019-03-14 16:25:03
Documents
3
Group Members
SYNCONA HOLDINGS LTDSYNCONA INVESTMENT MANAGEMENT LTDSYNCONA LTD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A (AMENDMENT NO. 2) d722862dsc13ga.htm SC 13G/A 68708
2 EXHIBIT 99.1 d722862dex991.htm EX-99.1 5587
3 EXHIBIT 99.2 d722862dex992.htm EX-99.2 55344
  Complete submission text file 0001193125-19-074839.txt   131471
Mailing Address C/O NIGHTSTAR, INC. 203 CRESCENT STREET, SUITE 303 WALTHAM MA 02453
Business Address C/O NIGHTSTAR, INC. 203 CRESCENT STREET, SUITE 303 WALTHAM MA 02453 781-778-7553
Nightstar Therapeutics plc (Subject) CIK: 0001711675 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90131 | Film No.: 19681387
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 2ND FLOOR 8 BLOOMSBURY STREET LONDON X0 WC1B 3SR
Business Address 3RD FLOOR, ARNOLD HOUSE PO BOX 273, ST JULIAN'S AVENUE ST PETER PORT Y7 GY1 3RD 001442039817909
Syncona Portfolio Ltd (Filed by) CIK: 0001725042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y7 | Fiscal Year End: 0331
Type: SC 13G/A